SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-218504
Filing Date
2022-08-11
Accepted
2022-08-11 16:03:00
Documents
45
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d357407d10q.htm   iXBRL 10-Q 630230
2 EX-31.1 d357407dex311.htm EX-31.1 10239
3 EX-31.2 d357407dex312.htm EX-31.2 10257
4 EX-32.1 d357407dex321.htm EX-32.1 3792
5 EX-32.2 d357407dex322.htm EX-32.2 3810
  Complete submission text file 0001193125-22-218504.txt   3430831

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbax-20220630.xsd EX-101.SCH 39266
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbax-20220630_cal.xml EX-101.CAL 18110
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbax-20220630_def.xml EX-101.DEF 198423
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbax-20220630_lab.xml EX-101.LAB 231399
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbax-20220630_pre.xml EX-101.PRE 230666
39 EXTRACTED XBRL INSTANCE DOCUMENT d357407d10q_htm.xml XML 431076
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40877 | Film No.: 221155578
SIC: 6770 Blank Checks